Clinical Trial Update: Coenzyme Q10 and Chemotherapeutic Toxicity in Breast Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Coenzyme Q10 to mitigate chemotherapy-related toxicity in breast cancer patients has completed. The sponsor is Damanhour Uni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: Damanhour University | Conditions: Breast Cancer, Chemotherapeutic Toxicity | Phase 2 | Status: COMPLETED